Contraception
Volume 73, Issue 5 , Pages 445-469 , May 2006

Combined hormonal contraception and bone health: a systematic review

  • Summer L. Martins

      Affiliations

    • Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    • ,
  • Kathryn M. Curtis

      Affiliations

    • Division of Reproductive Health, WHO Collaborating Center in Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 770 488 6397; fax: 770 488 6391.
    • ,
  • Anna F. Glasier

      Affiliations

    • Family Planning & Well Woman Services, National Health Service, Lothian Primary & Community Division, Edinburgh EH4 1NL, Scotland, UK
    • School of Clinical Sciences and Community Health, University of Edinburgh, Edinburgh EH8 9AG, Scotland, UK
    • Department of Public Health Policy, School of Hygiene and Tropical Medicine, University of London, London WC1E 7HT, England, UK

Received 14 December 2005 ,Accepted 5 January 2006.

References 

  1. Cromer BA. Effects of hormonal contraceptives on bone mineral density. Drug Saf. 1999;20:213–222
  2. DeCherney A. Bone-sparing properties of oral contraceptives. Am J Obstet Gynecol. 1996;174:15–20
  3. Kuohung W, Borgatta L, Stubblefield P. Low-dose oral contraceptives and bone mineral density: an evidence-based analysis. Contraception. 2000;61:77–82
  4. Williams JK. Noncontraceptive benefits of oral contraceptive use: an evidence-based approach. Int J Fertil Womens Med. 2000;45:241–247
  5. Compston J. Sex steroids and bone. Physiol Rev. 2001;81:419–447
  6. Castelo-Branco C, Vicente JJ, Pons F, Martinez de Osaba MJ, Casals E, Vanrell JA. Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives. J Reprod Med. 2001;46:875–879
  7. Haenggi W, Casez J-P, Birkhauser M, Lippuner K, Jaeger P. Bone mineral density in young women with long-standing amenorrhea: limited effect of hormone replacement therapy with ethinylestradiol and desogestrel. Osteoporos Int. 1994;4:99–103
  8. Hergenroeder AC, Smith EO, Shypailo R, Jones LA, Klish WJ, Ellis K. Bone mineral changes in young women with hypothalamic amenorrhea treated with oral contraceptives, medroxyprogesterone, or placebo over 12 months. Am J Obstet Gynecol. 1997;176:1017–1025
  9. Rickenlund A, Carlstrom K, Ekblom B, Brismar TB, Von SB, Hirschberg AL. Effects of oral contraceptives on body composition and physical performance in female athletes. J Clin Endocrinol Metab. 2004;89:4364–4370
  10. Seeman E, Szmukler GI, Formica C, Tsalamandris C, Mestrovic R. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res. 1992;7:1467–1474
  11. Doren M, Nilsson J, Johnell O. Effects of specific post-menopausal hormone therapies on bone mineral density in post-menopausal women: a meta-analysis. Hum Reprod. 2003;18:1737–1746
  12. WHO . Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1994;843:1–129
  13. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–1259
  14. Melton LJ, Crowson C, O'Fallon W, Wahner H, Riggs L. Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction. J Bone Miner Res. 2003;18:312–318
  15. Siris E, Brenneman S, Miller P, et al. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50–64 and 65 and older: results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res. 2004;19:1215–1220
  16. Grimes D, Schulz K. Surrogate end points in clinical research: hazardous to your health. Obstet Gynecol. 2005;105:1114–1118
  17. Sandor T, Felsenberg D, Brown E. Comments on the hypotheses underlying fracture risk assessment in osteoporosis as proposed by the World Health Organization. Calcif Tissue Int. 1999;64:267–270
  18. Schonau E. The peak bone mass concept: is it still relevant?. Pediatr Nephrol. 2004;19:825–831
  19. Harris R, Helfand M, Woolf S, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20:20–35
  20. Cooper C, Hannaford P, Croft P, Kay CR. Oral contraceptive pill use and fractures in women: a prospective study. Bone. 1993;14:41–45
  21. Johansson C, Mellstrom D. An earlier fracture as a risk factor for new fracture and its association with smoking and menopausal age in women. Maturitas. 1996;24:97–106
  22. La Vecchia C, Tavani A, Gallus S. Oral contraceptives and risk of hip fractures. Lancet. 1999;354:335–336
  23. Mallmin H, Ljunghall S, Persson I, Bergstrom R. Risk factors for fractures of the distal forearm: a population-based case-control study. Osteoporos Int. 1994;4:298–304
  24. Michaelsson K, Baron JA, Farahmand BY, Persson I, Ljunghall S. Oral contraceptive use and risk of hip fracture: a case-control study. Lancet. 1999;353:1481–1484
  25. Michaelsson K, Baron JA, Farahmand BY, Ljunghall S. Influence of parity and lactation on hip fracture risk. Am J Epidemiol. 2001;153:1166–1172
  26. O'Neill TW, Marsden D, Adams JE, Silman AJ. Risk factors, falls, and fracture of the distal forearm in Manchester, UK. J Epidemiol Community Health. 1996;50:288–292
  27. O'Neill TW, Silman AJ, Naves DM, Cooper C, Kanis J, Felsenberg D. Influence of hormonal and reproductive factors on the risk of vertebral deformity in European women. European Vertebral Osteoporosis Study Group. Osteoporos Int. 1997;7:72–78
  28. Tuppurainen M, Kroger H, Saarikoski S, Honkanen R, Alhava E. The effect of previous oral contraceptive use on bone mineral density in perimenopausal women. Osteoporos Int. 1994;4:93–98
  29. Vessey M, Mant J, Painter R. Oral contraception and other factors in relation to hospital referral for fracture. Findings in a large cohort study. Contraception. 1998;57:231–235
  30. Barad D, Kooperberg C, Wactawsi-Wende J, Liu J, Hendrix S, Watts N. Prior oral contraception and postmenopausal fracture: a Women's Health Initiative observational cohort study. Fertil Steril. 2005;84:374–383
  31. Afghani A, Abbott AV, Wiswell RA, et al. Bone mineral density in Hispanic women: role of aerobic capacity, fat-free mass, and adiposity. Int J Sports Med. 2004;25:384–390
  32. Beksinska M, Smit J, Kleinschmidt I, Farley T, Mbatha F. Bone mineral density in women aged 40–49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception. Contraception. 2005;71:170–175
  33. Berning B, van KC, Schutte HE, Kuiper JW, Drogendijk AC, Fauser BC. Determinants of lumbar bone mineral density in normal weight, non-smoking women soon after menopause. A study using clinical data and quantitative computed tomography. Bone Miner. 1993;21:129–139
  34. Collins C, Thomas K, Harding A, Cook S, Turner J, Collins J. The effect of oral contraceptives on lumbar bone density in premenopausal women. J La State Med Soc. 1988;140:35–39
  35. Forsmo S, Schei B, Langhammer A, Forsen L. How do reproductive and lifestyle factors influence bone density in distal and ultradistal radius of early postmenopausal women? The Nord-Trondelag Health Survey, Norway. Osteoporos Int. 2001;12:222–229
  36. Fortney JA, Feldblum PJ, Talmage RV, Zhang J, Godwin SE. Bone mineral density and history of oral contraceptive use. J Reprod Med. 1994;39:105–109
  37. Garnero P, Sornay-Rendu E, Delmas PD. Decreased bone turnover in oral contraceptive users. Bone. 1995;16:499–503
  38. Goldsmith N, Johnston J. Bone mineral: effects of oral contraceptives, pregnancy, and lactation. J Bone Joint Surg. 1975;57-A:657–668
  39. Grainge MJ, Coupland CAC, Cliffe SJ, Chilvers CED, Hosking DJ. Reproductive, menstrual and menopausal factors: which are associated with bone mineral density in early postmenopausal women?. Osteoporos Int. 2001;12:777–787
  40. Hall ML, Heavens J, Cullum ID, Ell PJ. The range of bone density in normal British women. J Bone Joint Surg. 1990;63:266–269
  41. Hansen MA. Assessment of age and risk factors on bone density and bone turnover in healthy premenopausal women. Osteoporos Int. 1994;4:123–128
  42. Hartard M, Bottermann P, Bartenstein P, Jeschke D, Schwaiger M. Effects on bone mineral density of low-dosed oral contraceptives compared to and combined with physical activity. Contraception. 1997;55:87–90
  43. Hawker GA, Forsmo S, Cadarette SM, et al. Correlates of forearm bone mineral density in young Norwegian women: the Nord-Trondelag health study. Am J Epidemiol. 2002;156:418–427
  44. Hreshchyshyn MM, Hopkins A, Zylstra S, Anbar M. Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol. 1988;159:318–322
  45. Johnell O, Nilsson BE. Life-style and bone mineral mass in perimenopausal women. Calcif Tissue Int. 1984;36:354–356
  46. Kanders B, Lindsay R, Dempster D. Determinants of bone mass in young healthy women. In:  Christiansen C,  Arnaud C,  Nordin B,  Parfitt A,  Peck W,  Riggs B editor. Proceedings of the Copenhagen International Symposium on Osteoporosis, Copenhagen. Denmark: Department of Clinical Chemistry, Glostrup Hospital; 1984;p. 337–339
  47. Kleerekoper M, Brienza RS, Schultz LR, Johnson CC. Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group. Arch Intern Med. 1991;151:1971–1976
  48. Kritz-Silverstein E, Barrett-Connor D. Bone mineral density in postmenopausal women as determined by prior oral contraceptive use. Am J Public Health. 1993;83:100–102
  49. Laitinen K, Valimaki M, Keto P. Bone mineral density measured by dual-energy X-ray absorptiometry in healthy Finnish women. Calcif Tissue Int. 1991;48:224–231
  50. Lau EMC, Lynn H, Woo J, Melton LJ. Areal and volumetric bone density in Hong Kong Chinese: a comparison with Caucasians living in the United States. Osteoporos Int. 2003;14:583–588
  51. Lindsay R, Tohme J, Kanders B. The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women. Contraception. 1986;34:333–340
  52. Lloyd T, Buchanan JR, Ursino GR, Myers C, Woodward G, Halbert DR. Long-term oral contraceptive use does not affect trabecular bone density. Am J Obstet Gynecol. 1989;160:402–404
  53. Lloyd T, Taylor DS, Lin HM, Matthews AE, Eggli DF, Legro RS. Oral contraceptive use by teenage women does not affect peak bone mass: a longitudinal study. Fertil Steril. 2000;74:734–738
  54. Lloyd T, Petit MA, Lin HM, Beck TJ. Lifestyle factors and the development of bone mass and bone strength in young women. J Pediatr. 2004;144:776–782
  55. MacDougall J, Davies MC, Overton CE, et al. Bone density in a population of long term oral contraceptive pill users does not differ from that in menstruating women. Br J Fam Plann. 1999;25:96–100
  56. Masaryk P, Lunt M, Benevolenskaya L, et al. Effects of menstrual history and use of medications on bone mineral density: the EVOS study. Calcif Tissue Int. 1998;63:271–276
  57. Melton LJ, Bryant SC, Wahner HW, et al. Influence of breastfeeding and other reproductive factors on bone mass later in life. Osteoporos Int. 1993;3:76–83
  58. Murphy S, Khaw KT, Compston JE. Lack of relationship between hip and spine bone mineral density and oral contraceptive use. Eur J Clin Invest. 1993;23:108–111
  59. Nelson M, Mayer AB, Rutherford O, Jones D. Calcium intake, physical activity and bone mass in pre-menopausal women. J Hum Nutr Diet. 1991;4:171–178
  60. Ott SM, Scholes D, LaCroix AZ, Ichikawa LE, Yoshida CK, Barlow WE. Effects of contraceptive use on bone biochemical markers in young women. J Clin Endocrinol Metab. 2001;86:179–185
  61. Pasco JA, Kotowicz MA, Henry MJ, Panahi S, Seeman E, Nicholson GC. Oral contraceptives and bone mineral density: a population-based study. Am J Obstet Gynecol. 2000;182:265–269
  62. Perrotti M, Bahamondes L, Petta C, Castro S. Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate. Fertil Steril. 2001;76:469–473
  63. Petitti DB, Piaggio G, Mehta S, Cravioto MC, Meirik O. Steroid hormone contraception and bone mineral density: a cross-sectional study in an international population. The WHO Study of Hormonal Contraception and Bone Health. Obstet Gynecol. 2000;95:736–744
  64. Picard D, Ste-Marie LG, Coutu D, et al. Premenopausal bone mineral content relates to height, weight and calcium intake during early adulthood. Bone Miner. 1988;4:299–309
  65. Prior JC, Kirkland SA, Joseph L, et al. Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. CMAJ. 2001;165:1023–1029
  66. Progetto Menopausa Italia Study Group. Risk of low bone density in women attending menopause clinics in Italy. Maturitas. 2002;42:105–111
  67. Rodin A, Chapman M, Fogelman I. Bone density in users of combined oral contraception. Preliminary reports of a pilot study. Br J Fam Plann. 1991;16:125–129
  68. Sowers MF, Wallace RB, Lemke JH. Correlates of forearm bone mass among women during maximal bone mineralization. Prev Med. 1985;14:585–596
  69. Stevenson JC, Lees B, Devenport M, Cust MP, Ganger KF. Determinants of bone density in normal women: risk factors for future osteoporosis?. Br Med J (Clin Res Ed). 1989;298:924–928
  70. Sultana S, Choudhury S, Choudhury SA. Effect of combined oral contraceptives on bone mineral density in pre and postmenopausal women. Mymensingh Med J. 2002;11:12–14
  71. Tavani A, La VC, Franceschi S. Oral contraceptives and bone mineral density. Am J Obstet Gynecol. 2001;184:249–250
  72. Tharnprisarn W, Taneepanichskul S. Bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate: a cross-sectional study in young Thai women. Contraception. 2002;66:101–103
  73. Ulrich CM, Georgiou CC, Snow-Harter CM, Gillis DE. Bone mineral density in mother–daughter pairs: relations to lifetime exercise, lifetime milk consumption, and calcium supplements. Am J Clin Nutr. 1996;63:72–79
  74. Wallace LS, Ballard JE. Lifetime physical activity and calcium intake related to bone density in young women. J Womens Health Gend Based Med. 2002;11:389–398
  75. Wanichsetakul P, Kamudhamas A, Watanaruangkovit P, Siripakarn Y, Visutakul P. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception. Contraception. 2002;65:407–410
  76. Berenson AB, Radecki CM, Grady JJ, Rickert VI, Thomas A. A prospective, controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol. 2001;98:576–582
  77. Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A. Effects of hormonal contraception on bone mineral density after 24 months of use. Obstet Gynecol. 2004;103:899–906
  78. Cobb KL, Kelsey JL, Sidney S, Ettinger B, Lewis CE. Oral contraceptives and bone mineral density in white and black women in CARDIA. Coronary Risk Development in Young Adults. Osteoporos Int. 2002;13:893–900
  79. Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr. 1996;129:671–676
  80. Cromer BA, Stager M, Bonny A, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health. 2004;35:434–441
  81. Elgan C, Samsioe G, Dykes AK. Influence of smoking and oral contraceptives on bone mineral density and bone remodeling in young women: a 2-year study. Contraception. 2003;67:439–447
  82. Elgan C, Dykes AK, Samsioe G. Bone mineral density changes in young women: a two year study. Gynecol Endocrinol. 2004;19:169–177
  83. Endrikat J, Mih E, Dusterberg B, et al. A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 microg or 30 microg ethinylestradiol in combination with levonorgestrel on bone mineral density. Contraception. 2004;69:179–187
  84. Gambacciani M, Spinetti A, Cappagli B, et al. Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: effects on bone mineral density and metabolism. Maturitas. 1994;19:125–131
  85. Gambacciani M, Spinetti A, Taponeco F, Cappagli B, Piaggesi L, Fioretti P. Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Obstet Gynecol. 1994;83:392–396
  86. Gambacciani M, Cappagli B, Ciaponi M, Benussi C, Genazzani AR. Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics. Menopause. 1999;6:43–48
  87. Gambacciani M, Ciaponi M, Cappagli B, Benussi C, Genazzani AR. Longitudinal evaluation of perimenopausal femoral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Osteoporos Int. 2000;11:544–548
  88. Hansen M, Overgaard K, Riis B, Christiansen C. Potential risk factors for development of postmenopausal osteoporosis-examined over a 12-year period. Osteoporos Int. 1991;1:95–102
  89. Lara-Torre E, Edwards CP, Perlman S, Hertweck SP. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol. 2004;17:17–21
  90. Mazess RB, Barden HS. Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pills. Am J Clin Nutr. 1991;53:132–142
  91. Nappi C, Di Spiezio SA, Acunzo G, et al. Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study. Contraception. 2003;67:355–359
  92. Nappi C, Di Spiezio SA, Greco E, Tommaselli GA, Giordano E, Guida M. Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density. Obstet Gynecol. 2005;105:53–60
  93. Paoletti AM, Orru M, Lello S, et al. Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women. Contraception. 2004;70:293–298
  94. Polatti F, Perotti F, Filippa N, Gallina D, Nappi RE. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception. 1995;51:221–224
  95. Recker RR, Davies KM, Hinders SM, Heaney RP, Stegman MR, Kimmel DB. Bone gain in young adult women. JAMA. 1992;268:2403–2408
  96. Reed SD, Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Longitudinal changes in bone density in relation to oral contraceptive use. Contraception. 2003;68:177–182
  97. Shargil AA. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study. Int J Fertil. 1985;30:15–28
  98. Taechakraichana N, Limpaphayom K, Ninlagarn T, Panyakhamlerd K, Chaikittisilpa S, Dusitsin N. A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women. Obstet Gynecol. 2000;95:87–94
  99. Taechakraichana N, Jaisamrarn U, Panyakhamlerd K, Chaikittisilpa S, Limpaphayom K, et al. Difference in bone acquisition among hormonally treated postmenopausal women with normal and low bone mass. J Med Assoc Thai. 2001;84(Suppl 2):S586–S592
  100. Volpe A, Amram A, Cagnacci A, Battaglia C. Biochemical aspects of hormonal contraception: effects on bone metabolism. Eur J Contracept Reprod Health Care. 1997;2:123–126
  101. Weaver CM, Teegarden D, Lyle RM, et al. Impact of exercise on bone health and contraindication of oral contraceptive use in young women. Med Sci Sports Exerc. 2001;33:873–880
  102. Mais V, Fruzzetti F, Ajossa S, Paoletti AM, Guerriero S, Melis GB. Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol: a prospective study. Contraception. 1993;48:445–452
  103. Volpe A, Silferi M, Genazzani AD, Genazzani AR. Contraception in older woman. Contraception. 1993;47:229–239
  104. von Kesseru E, Etchepareborda JJ, Wikinski R, Beier S. Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. Contraception. 2000;61:317–322
  105. Massai R, Makarainen L, Kuukankorpi A, Klipping C, Duijkers I, Dieben T. The combined contraceptive vaginal ring (NuvaRing) and bone mineral density in healthy premenopausal women. Hum Reprod. 2005;20:2764–2768
  106. Kanis J. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002;359:1929–1936

PII: S0010-7824(06)00009-6

doi: 10.1016/j.contraception.2006.01.003

Contraception
Volume 73, Issue 5 , Pages 445-469 , May 2006

Article Tools

* Image Usage & Resolution